50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
NASDAQ:SPRO

Spero Therapeutics - SPRO Short Interest Ratio & Short Volume

$1.97
-0.08 (-3.90%)
(As of 09/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.91
$2.07
50-Day Range
$0.68
$2.20
52-Week Range
$0.68
$18.84
Volume
2.16 million shs
Average Volume
2.81 million shs
Market Capitalization
$69.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.33

Spero Therapeutics Short Interest Data

Current Short Volume
777,200 shares
Previous Short Volume
275,600 shares
Change Vs. Previous Month
+182.00%
Dollar Volume Sold Short
$753,884.00
Short Interest Ratio / Days to Cover
0.1
Last Record Date
September 15, 2022
Outstanding Shares
35,067,000 shares
Float Size
27,110,000 shares
Short Percent of Float
2.87%
Today's Trading Volume
2,164,223 shares
Average Trading Volume
2,806,335 shares
Today's Volume Vs. Average
-22.88%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Spero Therapeutics ?

Sign up to receive the latest short interest report for Spero Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SPRO Short Interest Over Time

SPRO Days to Cover Over Time

SPRO Percentage of Float Shorted Over Time


Spero Therapeutics (NASDAQ:SPRO) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/2022777,200 shares $753,884.00 +182.0%2.9%0.1 $0.97
8/31/2022275,600 shares $222,381.64 -32.9%1.0%0.1 $0.81
8/15/2022410,600 shares $371,059.22 +1.1%1.5%1.3 $0.90
7/31/2022406,100 shares $297,346.42 -27.2%1.6%1.1 $0.73
7/15/2022557,800 shares $440,662.00 +34.9%2.3%0.8 $0.79
6/30/2022413,600 shares $306,477.60 -70.9%1.7%0.6 $0.74
6/15/20221,420,000 shares $1.36 million -9.0%5.8%1.9 $0.96
5/31/20221,560,000 shares $1.84 million -5.5%6.4%2.3 $1.18
5/15/20221,650,000 shares $2.82 million -55.3%6.8%2.6 $1.71
4/30/20223,690,000 shares $17.93 million +6.7%14.6%6.3 $4.86
4/15/20223,460,000 shares $21.14 million +6.5%13.7%16.7 $6.11
3/31/20223,250,000 shares $28.28 million +4.2%13.1%16.5 $8.70
3/15/20223,120,000 shares $25.40 million +5.4%12.6%18.6 $8.14
2/28/20222,960,000 shares $28.42 million +5.7%11.9%20.8 $9.60
2/15/20222,800,000 shares $27.94 million +12.0%11.3%19.6 $9.98
1/31/20222,500,000 shares $29.68 million +4.6%10.1%18.6 $11.87
1/15/20222,390,000 shares $31.55 million +4.4%9.4%21.1 $13.20
12/31/20212,290,000 shares $36.66 million -1.7%9.0%23.2 $16.01
12/15/20212,330,000 shares $30.64 million -0.9%9.2%24.5 $13.15
11/30/20212,350,000 shares $33.49 million -2.5%9.3%23.9 $14.25
11/15/20212,410,000 shares $39.55 million -3.6%9.5%22.4 $16.41
10/29/20212,500,000 shares $43.90 million No Change9.9%21 $17.56
10/15/20212,500,000 shares $42.55 million -1.2%9.9%21.4 $17.02
9/30/20212,530,000 shares $46.58 million -1.9%10.0%20.4 $18.41
9/15/20212,580,000 shares $47.81 million -4.1%10.2%16.4 $18.53
8/31/20212,690,000 shares $51.78 million +1.9%10.9%15.8 $19.25
8/13/20212,640,000 shares $35.69 million No Change10.7%16.5 $13.52
7/30/20212,640,000 shares $35.22 million No Change11.6%17 $13.34
7/15/20212,640,000 shares $37.73 million +10.0%12.1%16.6 $14.29
6/30/20212,400,000 shares $33.50 million -23.1%9.9%14.5 $13.96
6/15/20213,120,000 shares $47.55 million -1.0%12.9%22.1 $15.24
5/28/20213,150,000 shares $45.68 million -3.4%13.0%20.3 $14.50
5/14/20213,260,000 shares $42.28 million -2.1%N/A19.9 $12.97
4/30/20213,330,000 shares $45.59 million -2.1%N/A17.5 $13.69
4/15/20213,400,000 shares $44.81 million +0.6%N/A14 $13.18
3/31/20213,380,000 shares $46.04 million +50.9%N/A12.9 $13.62
3/15/20212,240,000 shares $37.50 million +1.8%N/A6.7 $16.74
2/26/20212,200,000 shares $40.44 million -1.8%N/A6.6 $18.38
2/12/20212,240,000 shares $45.52 million -0.4%N/A6.6 $20.32
1/29/20212,250,000 shares $40.95 million +0.9%N/A6.4 $18.20













SPRO Short Interest - Frequently Asked Questions

What is Spero Therapeutics' current short interest?

Short interest is the volume of Spero Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 777,200 shares of SPRO short. 2.87% of Spero Therapeutics' shares are currently sold short. Learn More on Spero Therapeutics' current short interest.

Which institutional investors are shorting Spero Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Spero Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Spero Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.87% of Spero Therapeutics' floating shares are currently sold short.

Is Spero Therapeutics' short interest increasing or decreasing?

Spero Therapeutics saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 777,200 shares, an increase of 182.0% from the previous total of 275,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Spero Therapeutics' float size?

Spero Therapeutics currently has issued a total of 35,067,000 shares. Some of Spero Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Spero Therapeutics currently has a public float of 27,110,000 shares.

How does Spero Therapeutics' short interest compare to its competitors?

2.87% of Spero Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Spero Therapeutics: BioVie Inc. (14.06%), Eyenovia, Inc. (1.04%), Trevi Therapeutics, Inc. (0.23%), Reneo Pharmaceuticals, Inc. (0.72%), Genprex, Inc. (3.67%), Oncolytics Biotech Inc. (0.34%), Lumos Pharma, Inc. (5.07%), SCYNEXIS, Inc. (3.03%), Equillium, Inc. (6.52%), and Frequency Therapeutics, Inc. (2.14%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($4.11 billion), Canadian Natural Resources Limited ($3.64 billion), Charter Communications, Inc. ($3.15 billion), Lucid Group, Inc. ($2.09 billion), Chesapeake Energy Co. ($2.02 billion), Coinbase Global, Inc. ($2.01 billion), T. Rowe Price Group, Inc. ($1.92 billion), Plug Power Inc. ($1.77 billion), Rivian Automotive, Inc. ($1.71 billion), and Williams-Sonoma, Inc. ($1.59 billion). View all of the most shorted stocks.

What does it mean to sell short Spero Therapeutics stock?

Short selling SPRO is an investing strategy that aims to generate trading profit from Spero Therapeutics as its price is falling. SPRO shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Spero Therapeutics?

A short squeeze for Spero Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRO, which in turn drives the price of the stock up even further.

How often is Spero Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRO, twice per month. The most recent reporting period available is September, 15 2022.



This page (NASDAQ:SPRO) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.